Hepion Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.55-$4.47 |
Market Cap | $4.6M |
Shares Short | 65,726 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.40 |
News
See moreYahoo Finance • 12 months ago
Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit
Yahoo Finance • last year
Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver Disease
About
CEO | Mr. John Patrick Brancaccio CPA |
CFO | Mr. John Patrick Brancaccio CPA |
Address | 399 Thornall Street, Edison, NJ, United States, 08837 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 22 |
